Signals mentioning Dr. Sheth's
- Honasa targets Rs 5,500 crore revenue and 15% EBITDA margin by FY31
- Honasa targets ₹5,550 crore revenue and 15% EBITDA margin by FY31
- Honasa calls off ₹135 crore acquisition of 58% stake in Fluence Pharma
- Be Clinical raises ₹21 Cr to scale clinical skincare R&D and manufacturing
- Honasa hits 52-week high after ₹756 crore quarterly revenue, ₹90 crore PAT
- Honasa’s Q1 profit more than doubles as it launches FIKN fragrance brand
- Honasa PAT more than doubles to ₹90 crore as offline reach hits 3 lakh outlets
- Honasa Consumer guides to ~30% Q1 FY27 growth, led by Mamaearth and younger brands
- Honasa Consumer projects ~30% revenue growth in Q1 FY27, double-digit margins hold
- Honasa Consumer Guides 30% Q1 FY27 Revenue Growth, Targets ₹5,500 Cr by FY31
- Honasa guides to ~30% Q1 FY27 revenue growth, double-digit operating margins
- Honasa pivots from Mamaearth-only D2C to multi-brand FMCG play targeting HUL, P&G, Marico
- Honasa pushes beyond Mamaearth to challenge HUL, P&G and Marico with multi-brand FMCG play
- Sofina Ventures Trims Honasa Stake With ₹177 Cr Bulk Deal at ₹424/Share
- Sofina Ventures exits 1.28% of Honasa Consumer in ₹177 Cr bulk deal at ₹424/share
- Sofina Ventures exits 1.28% of Honasa Consumer in ₹177 Cr bulk deal at ₹424/share
- Sofina Ventures exits 1.28% of Honasa Consumer in ₹177 Cr bulk deal at ₹424/share
- Honasa buys 58% of Fluence Pharma for ₹135 Cr, enters nutraceuticals via Honasa Health
- Honasa eyes ₹5,500 cr by FY31 as Q4 revenue jumps 23% and margins recover
- Honasa targets ₹5,500 Cr revenue by FY31, more than doubling FY26 base